Dose-ranging and safety with intravenous levosimendan in low-output heart failure Experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trial /
A series of dose-ranging and tolerability studies of intravenous levosimendan (bolus then infusion) were conducted in 40 patients with low-output heart failure (cardiac index <2.5 L/m(2) per minute). These trials were conducted as preparation for the Levosimendan Infusion versus Dobutamine (LIDO)...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
1999
|
| Sorozat: | AMERICAN JOURNAL OF CARDIOLOGY
83 No. 12B |
| Tárgyszavak: | |
| mtmt: | 1131817 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/31512 |